Astrasentan becomes the first and only endothelin A receptor antagonist to focus on proteinuria reduction in primary ...
Zacks Investment Research on MSN2h
FDA Grants Accelerated Approval to NVS Kidney Disease DrugNovartis NVS obtains FDA approval of atrasentan, a potent and selective endothelin A (ETA) receptor antagonist, for the ...
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts, dialysis and transplantation are among the only treatments.
Novartis ( NYSE: NVS) said on Thursday that it received US FDA's accelerated approval for Vanrafia as a treatment for adults ...
Manipal Hospitals conducted an informative event on World Kidney Day, discussing kidney health's significance. Two expert ...
In a bid to highlight the increasing significance of kidney health, especially on the occasion of World Kidney Day, Manipal ...
For patients with polycystic kidney disease (PKD), a common genetic disorder that ravages the waste-removing organ with cysts ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback